World Health Organization site
Skip Navigation Links

Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Last refreshed on: 19 February 2015
Main ID:  NCT00307593
Date of registration: 24/03/2006
Prospective Registration: No
Primary sponsor: Assistance Publique - Hôpitaux de Paris
Public title: RATTRAP: Infliximab Versus Rituximab in Systemic Necrotizing Vasculitides
Scientific title: Infliximab Versus Rituximab in Systemic Necrotizing Vasculitides With Positive ANCA After Relapse or Resistant Immunosuppressant Therapies
Date of first enrolment: May 2004
Target sample size: 20
Recruitment status: Completed
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Factorial Assignment, Masking: Open Label, Primary Purpose: Treatment  
Phase:  N/A
Countries of recruitment
Name:     Loïc GUILLEVIN, MD, PhD
Affiliation:  Assistance Publique - Hôpitaux de Paris
Key inclusion & exclusion criteria

Inclusion Criteria:

- Systemic ANCA positive (+) vasculitides

- Relapsing or refractory vasculitides, resistant to corticosteroids and reference
immunosuppressant therapies

- Age >18 years old

- Written informed consent

Exclusion Criteria:

- Newly diagnosed patient

- Patient that had never received an immunosuppressant before to treat his/her

- Malignancy

- Pregnancy

Age minimum: 18 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Churg-Strauss Syndrome
Microscopic Polyangiitis
Wegener's Granulomatosis
Drug: Infliximab
Drug: Rituximab
Primary Outcome(s)
Partial or complete remission of the vasculitides [Time Frame: one year]
Secondary Outcome(s)
Churg-Strauss syndrome [Time Frame: one year]
Microscopic polyangiitis [Time Frame: one year]
To study the safety and adverse effects of both regimens [Time Frame: one year]
Wegener's granulomatosis [Time Frame: one year]
Secondary ID(s)
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results available:
Date Posted:
Date Completed:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history